Edition:
United States

vTv Therapeutics Inc (VTVT.OQ)

VTVT.OQ on NASDAQ Stock Exchange Global Market

2.92USD
15 Oct 2018
Change (% chg)

-- (--)
Prev Close
$2.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
356,648
52-wk High
$8.37
52-wk Low
$0.65

Chart for

About

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of orally administered small molecule drug candidates. Its drug candidate for the treatment of Alzheimer's disease (AD) is azeliragon (TTP488), an orally administered, small molecule antagonist targeting... (more)

Overall

Beta: --
Market Cap(Mil.): $204.09
Shares Outstanding(Mil.): 32.81
Dividend: --
Yield (%): --

Financials

  VTVT.OQ Industry Sector
P/E (TTM): -- 86.20 32.69
EPS (TTM): -1.67 -- --
ROI: -134.79 0.73 14.32
ROE: -- 1.82 16.04

BRIEF-vTv Therapeutics Q1 GAAP Loss Per Share $0.30

* VTV THERAPEUTICS REPORTS 2018 FIRST QUARTER FINANCIAL AND OPERATIONAL RESULTS AND RECENT HIGHLIGHTS

May 15 2018

BRIEF-VTV Therapeutics Announces Company Will Pre-Specify New Subgroup With The FDA

* VTV THERAPEUTICS ANNOUNCES COMPANY WILL PRE-SPECIFY NEW SUBGROUP WITH THE FDA AND REPORT PHASE 3 PART B RESULTS IN JUNE

May 09 2018

Earnings vs. Estimates